Method for multiple COVID-19 drugs analysis by LC-MS/MS

Application Note Comprehending COVID-19: LC-MS/MS Analysis of Small Molecule Anti-Viral and Anti-Inflammatory Drugs in Plasma in Clinical Research Dominic Foley, Lisa J. Calton, David Morrissey Waters Corporation Need Help? To learn more about how Waters can help you in your…

Application News No. C217 LC-MS Simultaneous Analysis of Remdesivir and Metabolites in Human plasma Using Fully Automated Sample Preparation LC/MS/MS System  Introduction Remdesivir (brand name: Veklury®), which was developed by Gilead Sciences (U.S.) for treatment of Ebola virus disease,…

Application News No. C217 LC-MS Simultaneous Analysis of Remdesivir and Metabolites in Human plasma Using Fully Automated Sample Preparation LC/MS/MS System  Introduction Remdesivir (brand name: Veklury®), which was developed by Gilead Sciences (U.S.) for treatment of Ebola virus disease,…

Application News No. C218 LC-MS Simultaneous Analysis of Remdesivir and Metabolites in Human Plasma  Introduction Table 1 LC and MS Analysis Conditions Remdesivir (brand name: Veklury®), which was developed by Gilead Science (U.S.) for treatment of Ebola virus disease,…